← Back to screener

CorMedix Inc. CRMD

Rank #2249 · Nasdaq · $0.4B market cap
Audited by CBIZ CPAs P.C, no going-concern flag in the latest filing.
Score
27.4
P/E
-24.9
P/B
6.37
ROE
-25.6%
Op. Margin
-51.4%
Debt Ratio
49%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Weak

P/E -24.9x, P/B 6.37x. Ranks in the top 74% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -25.6%. Ranks in the top 84% of the universe.

Safety ★★★★☆
Good

Debt ratio 49%. Ranks in the top 23% of the universe. Under 100% is generally considered a safe level.

Growth ★★☆☆☆
Weak

Revenue decline of 0.0% year over year. Ranks in the top 65% of the universe.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011–$-0.0B$-0.0B$-0.0B–-165
2012–$-0.0B$-0.0B$-0.0B–-137
2013$0.0B$-0.0B$-0.0B$-0.0B–-444
2014$0.0B$-0.0B$-0.0B$-0.0B-245646.9-2084
2015$0.0B$-0.0B$-0.0B$-0.0B-4703.3-36
2016$0.0B$-0.0B$-0.0B$-0.0B-4703.3-77
2017$0.0B$-0.0B$-0.0B$0.0B-11048.812
2018$0.0B$-0.0B$-0.0B$0.0B-9997.435
2019$0.0B$-0.0B$-0.0B$0.0B-6250.4193
2020$0.0B$-0.0B$-0.0B$0.0B-7416.3118
2021$0.0B$-0.0B$-0.0B$0.0B-11378.422
2022$0.0B$-0.0B$-0.0B$0.0B-15417.514
2023$0.0B$-0.0B$-0.0B$0.1B-46819.911
2024$0.0B$-0.0B$-0.0B$0.1B-112.622
2025$0.0B$-0.0B$-0.0B$0.1B-51.449

← See the full screener